Rp-cAMPS sodium salt is a membrane-permeable, competitive cAMP antagonist used to inhibit cAMP-induced activation of PKA I and PKA II; it blocks PKA activation by binding to the regulatory subunits without dissociating the kinase holoenzyme. It is employed to study synaptic plasticity, as it inhibits synaptic plasticity without affecting normal synaptic transmission. In research settings, it is used to investigate pain-related synaptic changes, as it significantly reduces monosynaptic EPSCs at PB-CeLC and BLA-CeLC synapses in brain slices from arthritic rats, but not in control neurons from normal animals.